| ★ | Delgocitinib & Hand Eczema: How Topical JAK Inhibitors Change the Treatment Sequence | Maui Derm | | 11 | Estados Unidos | |
| 20 | Gel Nails Triggering Hand Eczema | Dr. Daniel Sugai @danielsugaimd | — | Estados Unidos | 86 |
| 8 | How New Biologics Are Changing #AtopicDermatitis Treatment | | 274 | Estados Unidos | 87 |
| 9 | How New Biologics Are Changing #AtopicDermatitis Treatment | | 272 | Estados Unidos | 87 |
| 5 | Hair Loss Update 2026: JAK Inhibitors, Oral Minoxidil, and Sequencing | | 209 | Estados Unidos | 87 |
| 6 | Why Povorcitinib's JAK1 Mechanism Matters for HS, With Martina Porter, MD | | 172 | Estados Unidos | 87 |
| 10 | Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD | | 152 | Estados Unidos | 87 |
| 7 | Vitiligo Pipeline Update: George Martin, MD, on JAK Inhibitors & Melasma Treatment | | 143 | Estados Unidos | 87 |
| 4 | How Are New Biologics Changing Atopic Dermatitis Treatment? | | 137 | Estados Unidos | 88 |
| 18 | Key Off-Label Treatment Options in Dermatology, With Matthew Zirwas, MD | | 117 | Estados Unidos | 86 |
| 11 | Ruxolitinib, Tapinarof, Roflumilast: What's New for Pediatric AD | | 102 | Estados Unidos | 87 |
| 12 | What Is Next for OX40 Ligand Inhibition in Atopic Dermatitis? | | 91 | Estados Unidos | 87 |
| 13 | Prior Authorization, Precision Medicine, and Eczema Remission, With Jason Hawkes, MD | | 69 | Estados Unidos | 87 |
| 14 | Age-Stratified Phase 3 Data Support Tapinarof Cream in Pediatric Eczema | | 58 | Estados Unidos | 87 |
| 19 | Can CSU Patients Achieve True Remission? BTK Inhibitors, Biomarker Barriers, & More | EAC 2026 | | 58 | Estados Unidos | 86 |
| 15 | Discussing Zumilokibart Data in Atopic Dermatitis, With Ruth Ann Vleugels, MD, MPH, MBA | | 30 | Estados Unidos | 87 |
| 16 | Key Non-Medication Clinical Pearls for Dermatologists, With Matthew Zirwas, MD | | 21 | Estados Unidos | 86 |
| 3 | HCPLive Five: Maui Derm NP+PA Summer 2026 | | 20 | Estados Unidos | 89 |
| 2 | Are You Misdiagnosing Atopic Dermatitis? Matthew Zirwas, MD, on Adult-Onset AD | | 19 | Estados Unidos | 89 |
| 1 | Patch Testing, Nickel, & IL-13 Inhibitors: Rethinking Eczematous Dermatitis Diagnosis | | 11 | Estados Unidos | 91 |
| 17 | Evolving Safety Considerations in Atopic Dermatitis Management | | 3 | Estados Unidos | 86 |